Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Cell and Gene Therapy Catapult, The. (10/4/17). "Press Release: Innovate UK Announce Funding to Establish Network of Advanced Therapies Treatment Centres in the UK".

Region Region United Kingdom (GB)
Organisations Organisation Cell and Gene Therapy Catapult (CGT Catapult) (GB)
  Group United Kingdom (GB) (govt)
  Organisation 2 Innovate UK
  Group United Kingdom (GB) (govt)
Products Product business development (state/region)

UK companies, working with research organisations, can apply for a share of up to £30 million to support the creation of a network of advanced therapies treatment centres in the UK.

As part of the life sciences industrial strategy, Innovate UK has launched a competition through which UK companies, working with research organisations, can apply for a share of up to £30 million to support the creation of a network of advanced therapies treatment centres in the UK.

Advanced therapies are new and emerging medicines with potential uses in treating forms of blindness, cancer, heart failure, liver disease, neurological conditions and rare paediatric diseases. The network of Advanced Therapy Treatment Centres will be responsible for developing the systems and infrastructure to support delivery of cell and gene therapies, including final manufacture and supply, clinical trial capability, R&D approval, specialist clinician availability and support services.

The key to the success of the initiative will be a coordinated and efficient network of three centres. The network will set the UK apart globally for the delivery of clinical trials and the routine clinical delivery of cell and gene therapies. CGT Catapult will play a central coordinating role for the network as well as providing manufacturing, supply chain and reimbursement support.

Innovate UK is looking to fund activities that:

> increase patient access to advanced therapy medicinal products (ATMPs) on a national level
> establish best practice for the safe and effective delivery of ATMPs to patients
> establish best practice for the manufacturing and final preparation of ATMPs using Good Manufacturing Practice (GMP) within a clinical setting
> establish robust connected supply chains for the manufacture and delivery of ATMPs
> create systems to allow traceability and tracking of ATMPs. These must be compatible with current regulations and be suitable for applying across the NHS
> establish best practice for patient follow up and data capture

The funding will be delivered through a competitive process managed by Innovate UK with widespread industry involvement to develop and implement the new systems needed to allow these centres to operate.

Important information:

Competition opens: 29th September 2017
Project start date: noon 1st February 2018
Interview panel: 27th – 28th November 2017
Applicants informed: 8th December 2017
Competition website

If you are interested in learning more about the competition and potential partners please contact Dr Jacqueline Barry, Chief Clinical Officer.

Record changed: 2023-06-05


Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for United Kingdom (GB) (govt)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px

» top